collection of blood, urines, stool and tumor samples
collection of blood, urines, stool and tumor samples: blood, urines, stool will be collected during routine cares. Tumor samples from surgery will also be stored.
Study summary
The goal of this study is to collect tumor samples, urines, stool and blood from patients with urothelial carcinoma. These samples will be stored in a secure and confidential laboratory of the Toulouse University Hospital.
Eligibility
Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria:
* Adult \>18 years old
* Patient with suspected or diagnosed Urothelial carcinoma
* Patients who are willing to consent for this protocol.
Exclusion Criteria:
* Pregnant or breastfeeding patients
* Patients under 18 years old
* Patients under guardianship or curators
* Patients unable to sign a free and informed consent
Primary outcome measure(s)
Collection and long-term collection of blood, urines, stool and tumor samples from patients with Urothelial bladder carcinoma for future biological and/or surrogate marker studies. — Day 0 Transcriptomic analysis
Collection and long-term collection of blood, urines, stool and tumor samples from patients with Urothelial bladder carcinoma for future biological and/or surrogate marker studies. — during the intervention/procedure/surgery Transcriptomic, proteomic and epigenetic analysis
Trial sites (1)
Facility
City
Region
Status
Rangueil University Hospital
Toulouse
France
Recruiting
More University Hospital, Toulouse trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
